We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
Filings, earnings, research, and institutional changes — newest first
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
Consensus vs. actual, and revenue trend
Consensus PT $12.67 · 3 analysts
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
Stored first · Google News · Yahoo Finance (English)
Inogen Welcomes Three New Executive Team Members - Medical Product Outsourcing
Inogen Welcomes Three New Executive Team Members Medical Product Outsourcing
Freedom Broker initiates Inogen stock coverage with buy rating on respiratory platform growth - Investing.com
Freedom Broker initiates Inogen stock coverage with buy rating on respiratory platform growth Investing.com
Inogen Inc EVP Jennifer Yi Boyer sells $70,313 of common stock - Investing.com
Inogen Inc EVP Jennifer Yi Boyer sells $70,313 of common stock Investing.com
Inogen (INGN) HR chief sells 10,770 shares under Rule 10b5-1 plan - Stock Titan
Inogen (INGN) HR chief sells 10,770 shares under Rule 10b5-1 plan Stock Titan
Inogen (INGN) Q1 2026 Earnings Transcript - AOL.com
Inogen (INGN) Q1 2026 Earnings Transcript AOL.com
Here's Why You Should Retain Inogen Stock in Your Portfolio for Now
| Quarter | Date | Time | EPS est. | EPS actual | Surprise | Rev. est. | Rev. actual | Status |
|---|---|---|---|---|---|---|---|---|
| — | 2026. 08. 06. | After market close (AMC) | $-0.06 | — | — | $95.2M | — | Scheduled |
| FY2026 Q1 | 2025. 03. 31. | Time TBD | — | $-0.25 | — | — | $68.47M | Reported |
| FY2025 Q3 | 2024. 09. 30. | Time TBD | — | $-1.11 | — | — | $212.45M | Reported |
| FY2025 Q2 | 2024. 06. 30. | Time TBD | — | $-0.86 | — | — | $137.52M | Reported |
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2026. 04. 07. | Freedom Broker | — | Initiate coverage | — → Buy | — | Freedom Broker: Buy |
| 2025. 06. 17. | B. Riley Securities | — | Initiate coverage | — → Buy | — | B. Riley Securities: Buy |
| 2025. 05. 22. | Needham | — | Upgrade | Hold → Buy | — | Needham: Hold → Buy |
| 2025. 05. 08. | Stifel | — | Maintain | Hold → Hold | — | Stifel: Hold |
| 2025. 04. 09. | Needham | — | Maintain | Hold → Hold | — | Needham: Hold |
| 2025. 02. 27. | Needham | — | Maintain | Hold → Hold | — | Needham: Hold |
As of FY2026Q1 · Source: SEC/DART + price data
| # | Institution | Mandate | Shares | Value | Weight | Change | Position |
|---|---|---|---|---|---|---|---|
| 1 | Point72 Asset Management, L.P. | Point72 Asset Management, L.P. | 642,366 | $3.97B | 0.01% | — | New position |
| 2 | Point72 Asset Management, L.P. | Point72 Asset Management, L.P. | 201,949 | $1.36B | 0.00% | — | New position |
| 3 | TWO SIGMA INVESTMENTS, LP | TWO SIGMA INVESTMENTS, LP | 36,219 | $243.39M | 0.00% | — | New position |
| 4 | TWO SIGMA INVESTMENTS, LP | TWO SIGMA INVESTMENTS, LP | 11,519 | $71.19M | 0.00% | — | New position |